However, statistical analysis showed the significant association between TMB and mutations in EGFR, TP53, LRP1B, LRP2, and CDKN2A, suggesting potential biomarkers for the prognosis of Chinese lung cancer patients. The gene discussed is LRP1B; the disease is lung cancer.